How, J.A.; Jazaeri, A.A.; Fu, S.; Rodon Ahnert, J.; Gong, J.; Stephen, B.; Ferreira Dalla Pria, H.; Bhosale, P.; Johnson, A.; Yuan, Y.;
et al. Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials. Cancers 2022, 14, 3695.
https://doi.org/10.3390/cancers14153695
AMA Style
How JA, Jazaeri AA, Fu S, Rodon Ahnert J, Gong J, Stephen B, Ferreira Dalla Pria H, Bhosale P, Johnson A, Yuan Y,
et al. Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials. Cancers. 2022; 14(15):3695.
https://doi.org/10.3390/cancers14153695
Chicago/Turabian Style
How, Jeffrey A., Amir A. Jazaeri, Siqing Fu, Jordi Rodon Ahnert, Jing Gong, Bettzy Stephen, Hanna Ferreira Dalla Pria, Priya Bhosale, Amber Johnson, Ying Yuan,
and et al. 2022. "Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials" Cancers 14, no. 15: 3695.
https://doi.org/10.3390/cancers14153695
APA Style
How, J. A., Jazaeri, A. A., Fu, S., Rodon Ahnert, J., Gong, J., Stephen, B., Ferreira Dalla Pria, H., Bhosale, P., Johnson, A., Yuan, Y., Meric-Bernstam, F., & Naing, A.
(2022). Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials. Cancers, 14(15), 3695.
https://doi.org/10.3390/cancers14153695
